Fang Lu, Wei Heming, Chowdhury Sanual H, Gong Nanling, Song Jie, Heng Chew Kiat, Sethi Sunil, Koh Tian Hai, Chatterjee Subroto
Johns Hopkins Singapore-National Heart Centre Vascular Biology Program, National University of Singapore.
Indian J Med Res. 2005 Feb;121(2):92-9.
BACKGROUND & OBJECTIVES: Platelet endothelial cell adhesion molecule-1 (PECAM-1) plays a key role in the transendothelial migration of circulating leukocytes (diapedesis) during vascular inflammation. We hypothesized that genetic variation and the level of soluble PECAM-1 could be associated with the development of atherosclerosis and conducted a study on gene polymorphisms of PECAM-1 and soluble PECAM-1 levels in Asian Indian patients with coronary artery disease (CAD) in Singapore.
Of the 137 angiographically confirmed patients (> or =70% stenosis) of CAD and 110 controls in Asian Indian population, two single nucleotide polymorphisms (SNPs) of PECAM-1 gene, C+373G (Leu125Val) at exon 3 and G+1688A (Ser563Asn) at exon 8 were analyzed by polymerase chain reaction-restriction fragment-length polymorphism (PCR-RFLP) strategy. In addition, plasma soluble PECAM-1, P-selection and lipid profile were measured. Chi- square test and student t test were adopted to compare categorical and continuous variables, respectively.
A significant decrease in C allele frequency but increase in G allele frequency of the Leu125Val (C/G) polymorphism were observed in CAD patients as compared with controls (0.54/0.46 vs 0.663/0.337 respectively, P=0.008). Alteration in genotype distributions (CC, CG and GG) of the Leu125Val polymorphism between CAD patients and controls (P=0.009) was also significant. A similar trend was observed on the allele frequencies (G/A) and genotype distributions of Ser563Asn (G/A) polymorphism, though the difference did not reach significance. On the other hand, plasma level of soluble PECAM-1 (sPECAM-1) was markedly elevated in CAD patients (P=0.006), and associated with soluble P-selectin and lipid profiles.
INTERPRETATION & CONCLUSION: Our study showed that Leu125Val polymorphism of PECAM-1 gene and elevated soluble PECAM-1 were related to severe coronary artery stenosis in CAD patients of Asian Indian origin in Singapore. Our data also suggest that PECAM-1 plays an important role in the development of atherosclerosis.
血小板内皮细胞黏附分子-1(PECAM-1)在血管炎症期间循环白细胞的跨内皮迁移(渗出)中起关键作用。我们推测基因变异和可溶性PECAM-1水平可能与动脉粥样硬化的发生有关,并对新加坡亚裔印度裔冠心病(CAD)患者的PECAM-1基因多态性和可溶性PECAM-1水平进行了研究。
在亚裔印度人群中,对137例经血管造影证实的CAD患者(狭窄≥70%)和110例对照者,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)策略分析PECAM-1基因的两个单核苷酸多态性(SNP),即外显子3的C+373G(Leu125Val)和外显子8的G+1688A(Ser563Asn)。此外,检测血浆可溶性PECAM-1、P-选择素和血脂谱。分别采用卡方检验和学生t检验比较分类变量和连续变量。
与对照组相比,CAD患者Leu125Val(C/G)多态性的C等位基因频率显著降低,G等位基因频率升高(分别为0.54/0.46和0.663/0.337,P=0.008)。CAD患者和对照组之间Leu125Val多态性的基因型分布(CC、CG和GG)改变也有显著性差异(P=0.009)。Ser563Asn(G/A)多态性的等位基因频率(G/A)和基因型分布也观察到类似趋势,尽管差异未达到显著性。另一方面,CAD患者血浆可溶性PECAM-1(sPECAM-1)水平显著升高(P=0.006),且与可溶性P-选择素和血脂谱相关。
我们的研究表明,PECAM-1基因的Leu125Val多态性和可溶性PECAM-1升高与新加坡亚裔印度裔CAD患者的严重冠状动脉狭窄有关。我们的数据还表明,PECAM-1在动脉粥样硬化的发生中起重要作用。